Pacific Biosciences of California, Inc.

PACB Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of PACB by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
PACB Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
PACB Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
PACB Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in PACB holdings by institutional investors

Insider Trading

Quarterly net insider trading by PACB's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $60,000 Oct 20, 2022 Issue: Health Issues
  • $60,000 Oct 19, 2022 Issue: Health Issues
  • $60,000 Jul 20, 2022 Issue: Health Issues
  • $60,000 Jul 19, 2022 Issue: Health Issues
  • $60,000 Apr 20, 2022 Issue: Health Issues
  • $50,000 Apr 19, 2022 Issue: Health Issues
  • $50,000 Jan 20, 2022 Issue: Health Issues
  • $50,000 Jan 19, 2022 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues
  • $20,000 Jul 20, 2021 Issue: Medicare/Medicaid
  • $20,000 Jul 20, 2021 Issue: Health Issues
Corporate Lobbying

PACB Estimated quarterly lobbying spending

Revenue Breakdown

PACB Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
PACB Income Statement
PACB Balance Sheet
PACB Cash Flow
U.S. Patents

New PACB patent grants

  • Patent Title: Preparations, compositions, and methods for nucleic acid sequencing Aug. 05, 2014
  • Patent Title: Articles having localized molecules disposed thereon and methods of producing same Jul. 08, 2014
  • Patent Title: Sealed chip package Jul. 08, 2014
  • Patent Title: Loading molecules onto substrates May. 06, 2014
  • Patent Title: Arrays of optical confinements and uses thereof Apr. 29, 2014
  • Patent Title: Methods and processes for calling bases in sequence by incorporation methods Apr. 22, 2014
  • Patent Title: Nucleic acid synthesis compositions and methods and systems for using same Feb. 25, 2014
  • Patent Title: Isolation of polymerase-nucleic acid complexes Feb. 25, 2014
  • Patent Title: Cognate sampling kinetics Feb. 18, 2014
  • Patent Title: Nanopore sequencing using charge blockade labels Feb. 18, 2014
  • Patent Title: Integrated analytical system and method Feb. 11, 2014
  • Patent Title: Intermittent detection during analytical reactions Jan. 14, 2014
  • Patent Title: Substrates, systems and methods for analyzing materials Dec. 31, 2013
  • Patent Title: Single-molecule real-time analysis of protein synthesis Dec. 17, 2013
  • Patent Title: Single molecule sequencing with two distinct chemistry steps Dec. 10, 2013
  • Patent Title: Field-switch sequencing Nov. 26, 2013
  • Patent Title: Phospholink nucleotides for sequencing applications Nov. 12, 2013
  • Patent Title: Controllable strand scission of mini circle dna Oct. 08, 2013
  • Patent Title: Methods and compositions for nucleic acid sample preparation Sep. 17, 2013
  • Patent Title: Molecular redundant sequencing Sep. 17, 2013
  • Patent Title: Method for sequencing using branching fraction of incorporatable nucleotides Sep. 10, 2013
  • Patent Title: System and method for nucleic acid sequencing by polymerase synthesis Sep. 10, 2013
  • Patent Title: Method to improve single molecule analyses Aug. 27, 2013
  • Patent Title: Cis reactive oxygen quenchers integrated into linkers Aug. 06, 2013
  • Patent Title: Selectively functionalized arrays Aug. 06, 2013
  • Patent Title: Real-time sequencing methods and systems Aug. 06, 2013
  • Patent Title: Immobilized nucleic acid complexes for sequence analysis Jul. 09, 2013
  • Patent Title: Waveguide substrates and optical systems and methods of use thereof Jun. 25, 2013
  • Patent Title: Substrates, systems and methods for analyzing materials Jun. 25, 2013
  • Patent Title: Integrated analytical system and method Jun. 18, 2013
  • Patent Title: Methods and systems for monitoring reactions Jun. 18, 2013
  • Patent Title: Illumination of integrated analytical systems Jun. 18, 2013
  • Patent Title: Compositions and methods for nucleic acid sequencing Jun. 04, 2013
  • Patent Title: Generation of modified polymerases for improved accuracy in single molecule sequencing Apr. 16, 2013
  • Patent Title: Mitigation of photodamage in analytical reactions Apr. 09, 2013
  • Patent Title: Biotinylation tag peptides Mar. 05, 2013
  • Patent Title: Photo-induced damage mitigating agents and preparation and methods of use thereof Mar. 05, 2013
  • Patent Title: Intermittent detection during analytical reactions Feb. 26, 2013
  • Patent Title: Algorithms for sequence determination Feb. 05, 2013
  • Patent Title: Phospholink nucleotides for sequencing applications Feb. 05, 2013
  • Patent Title: Methods for producing zmws with islands of functionality Feb. 05, 2013
  • Patent Title: Labeled reactants and their uses Jan. 15, 2013
  • Patent Title: Polymerase enzymes and reagents for enhanced nucleic acid sequencing Jan. 01, 2013
  • Patent Title: Micromirror arrays having self aligned features Dec. 18, 2012
  • Patent Title: Surface comprising dna polymerase having mutations bound through an affinity tag Dec. 04, 2012
  • Patent Title: Substrate analysis systems Nov. 27, 2012
  • Patent Title: Diagnostic sequencing with small nucleic acid circles Nov. 13, 2012
  • Patent Title: Nucleic acid sequencing methods and systems Nov. 06, 2012
  • Patent Title: Substrates and optical system having at least one optical waveguide, at least one nanometer-scale aperture and at least one lens array and methods of use thereof Sep. 25, 2012
  • Patent Title: Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources Sep. 11, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to PACB from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
PACB News

Recent insights relating to PACB

CNBC Recommendations

Recent picks made for PACB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PACB

PACB Analyst Ratings

PACB Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
PACB Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $PACB stock a Buy, Sell, or Hold?

  • What is the price target for $PACB stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

PACB Top Shareholders
Shareholder
Shares Held
PACB Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $PACB stock?

  • Who owns the most shares of $PACB stock?

  • What funds own $PACB stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

PACB Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view PACB Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About PACB

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

  • Address Menlo Park, CA
  • Market Cap 670.2 million
  • Employees 575
  • Industrial Classification Laboratory Analytical Instruments
Back To Top